Influence of central and peripheral administration of pancreatic polypeptide on gastric mucosa growth. 2004

A Dembiński, and Z Warzecha, and P Ceranowicz, and M Pawlik, and M Dembiński, and K Kabat, and S J Konturek, and P Kownacki, and W Hładki, and W W Pawlik
Department of Physiology, Jagiellonian University Medical College, Cracow, Poland. mpdembin@cyf-kr.edu.pl

Previous studies have shown that pancreatic polypeptide (PP) inhibits exocrine pancreatic secretion. The aim of present study was to determine the influence of PP administration on gastric growth and blood flow. METHODS Study was performed on regularly fed, fasted or fasted and subsequently refed rats. Rats were treated with saline (intraperitoneally - i.p.), caerulein (0.24 nmol/kg/dose, i.p.), pentagastrin (0.38 micromol/kg/dose, i.p.) or PP (5 nmol/kg/dose, i.p. or 10 pmol/dose intracerebroventricularly - i.c.v.). Saline, caerulein, pentagastrin and PP were administered alone or in combination, 3 times daily during last 48 h of experiment. RESULTS Treatment with pentagastrin increased gastric mucosa weight, mucosal DNA synthesis and gastric blood flow in all group tested. Intraperitoneal and i.c.v administration of PP alone reduced mucosal DNA synthesis in regularly fed and refed animals, and decreased gastric blood flow in refed animals. Combination of PP i.p. or i.c.v plus pentagastrin significantly reduced the pentagastrin-evoked increase in gastric mucosa weight, gastric DNA synthesis and gastric blood flow in fasted animals, as well as regularly fed animals. In refed animals, influence of PP administration on the pentagastrin-evoked increase in gastric mucosa weight was weak and statistically insignificant, but still i.p or i.c.v administration of PP significantly reduced gastric blood flow and mucosal DNA synthesis in this group of animals. Administration of caerulein caused weak, but significant increase in gastric DNA synthesis, gastric mucosa weight and gastric blood flow in fasted rats. In regularly fed animals, caerulein significantly increased only gastric DNA synthesis and gastric blood flow. In fasted animals with subsequent refeeding, caerulein was without effect on parameters tested in the stomach. Neither i.p. nor i.c.v administration of PP affected the caerulein-evoked effects in the stomach. CONCLUSIONS Peripheral and central administration of PP inhibits food- and pentagastrin-stimulated growth of gastric mucosa. Similar effects of low central doses of PP as the high peripheral doses of PP suggests a crucial role of the central nervous system in the inhibitory effect of PP on gastric mucosa growth.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D008297 Male Males
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D010191 Pancreatic Polypeptide A 36-amino acid pancreatic hormone that is secreted mainly by endocrine cells found at the periphery of the ISLETS OF LANGERHANS and adjacent to cells containing SOMATOSTATIN and GLUCAGON. Pancreatic polypeptide (PP), when administered peripherally, can suppress gastric secretion, gastric emptying, pancreatic enzyme secretion, and appetite. A lack of pancreatic polypeptide (PP) has been associated with OBESITY in rats and mice. Pancreatic Polypeptide (PP),Pancreatic Polypeptide Hormone,Pancreatic Prohormone
D010295 Parietal Cells, Gastric Rounded or pyramidal cells of the GASTRIC GLANDS. They secrete HYDROCHLORIC ACID and produce gastric intrinsic factor, a glycoprotein that binds VITAMIN B12. Gastric Parietal Cells,Oxyntic Cells,Cell, Gastric Parietal,Cell, Oxyntic,Cells, Gastric Parietal,Cells, Oxyntic,Gastric Parietal Cell,Oxyntic Cell,Parietal Cell, Gastric
D010418 Pentagastrin A synthetic pentapeptide that has effects like gastrin when given parenterally. It stimulates the secretion of gastric acid, pepsin, and intrinsic factor, and has been used as a diagnostic aid. Acignost,Gastrin Pentapeptide,Peptavlon,Pentapeptide, Gastrin
D002108 Ceruletide A specific decapeptide obtained from the skin of Hila caerulea, an Australian amphibian. Caerulein is similar in action and composition to CHOLECYSTOKININ. It stimulates gastric, biliary, and pancreatic secretion; and certain smooth muscle. It is used in paralytic ileus and as diagnostic aid in pancreatic malfunction. Caerulein,Cerulein,Ceruletid,FI-6934,Takus,FI 6934,FI6934
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration

Related Publications

A Dembiński, and Z Warzecha, and P Ceranowicz, and M Pawlik, and M Dembiński, and K Kabat, and S J Konturek, and P Kownacki, and W Hładki, and W W Pawlik
November 1994, Digestive diseases and sciences,
A Dembiński, and Z Warzecha, and P Ceranowicz, and M Pawlik, and M Dembiński, and K Kabat, and S J Konturek, and P Kownacki, and W Hładki, and W W Pawlik
October 1988, Zeitschrift fur Gastroenterologie,
A Dembiński, and Z Warzecha, and P Ceranowicz, and M Pawlik, and M Dembiński, and K Kabat, and S J Konturek, and P Kownacki, and W Hładki, and W W Pawlik
August 1995, Experientia,
A Dembiński, and Z Warzecha, and P Ceranowicz, and M Pawlik, and M Dembiński, and K Kabat, and S J Konturek, and P Kownacki, and W Hładki, and W W Pawlik
June 1985, Poultry science,
A Dembiński, and Z Warzecha, and P Ceranowicz, and M Pawlik, and M Dembiński, and K Kabat, and S J Konturek, and P Kownacki, and W Hładki, and W W Pawlik
January 2017, Neurogastroenterology and motility,
A Dembiński, and Z Warzecha, and P Ceranowicz, and M Pawlik, and M Dembiński, and K Kabat, and S J Konturek, and P Kownacki, and W Hładki, and W W Pawlik
September 1982, Diabete & metabolisme,
A Dembiński, and Z Warzecha, and P Ceranowicz, and M Pawlik, and M Dembiński, and K Kabat, and S J Konturek, and P Kownacki, and W Hładki, and W W Pawlik
January 1992, Peptide research,
A Dembiński, and Z Warzecha, and P Ceranowicz, and M Pawlik, and M Dembiński, and K Kabat, and S J Konturek, and P Kownacki, and W Hładki, and W W Pawlik
June 2010, Peptides,
A Dembiński, and Z Warzecha, and P Ceranowicz, and M Pawlik, and M Dembiński, and K Kabat, and S J Konturek, and P Kownacki, and W Hładki, and W W Pawlik
March 1994, Gastroenterology,
A Dembiński, and Z Warzecha, and P Ceranowicz, and M Pawlik, and M Dembiński, and K Kabat, and S J Konturek, and P Kownacki, and W Hładki, and W W Pawlik
April 1980, Diabetes,
Copied contents to your clipboard!